NB

Niagen Bioscience Inc

NAGEยทNASDAQ

$3.46

-2.1%
HealthcareBiotechnology

Niagen Bioscience Inc is a bioscience company dedicated to healthy aging. The Company leads research on nicotinamide adenine dinucleotide.

At a Glance

Live Snapshot
Market Cap$275.97M
EPS0.2200
P/E Ratio15.75
Earnings Date08/05/2026

No Dividend Yield Data

NAGE has not reported any dividend yield values in the available annual periods.

No Dividend Payout Ratio Data

NAGE has not reported any dividend payout ratio values in the available annual periods.

No Net Dividends Paid Data

NAGE has not reported any net dividends paid values in the available annual periods.

NB

Niagen Bioscience Inc Dividend History

NAGE ยท NASDAQ
10Y CAGR +0%
Latest $0
Annual $0
Stable dividend payments
Last Period: +0%

NAGE Dividend Payment History

NAGE ยท NASDAQ
DeclarationEx-DatePayment DateDividendAdjustedFrequencyGrowth
No dividend payment history available
n

Niagen Bioscience Inc Payout Ratio Analysis

NAGE ยท NASDAQ
Dividends Paid
0.00
2025
Net Income
17.38M
2025
Payout Ratio
0.00%
2025

Dividend Sustainability Analysis

Payout Ratio
0.00%

Conservative payout with excellent safety margin. Company retains significant earnings for growth, acquisitions, or building cash reserves. Dividend is highly sustainable.

FCF Payout Ratio
0.0%

Excellent FCF coverage. Dividend is well-supported by actual cash generation with ample room for increases and business reinvestment.

Sustainability
Fair

Dividend sustainability questionable. Monitor closely for signs of stress. Consider whether yield justifies the risk.